Disease severity in sibling pairs with type 1 Gaucher disease
Authors:
- 5 January 2010
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 33 (1) , 79-83
Abstract
The only prognostic markers in Gaucher disease, the most common lysosomal storage disorder, are young age at first symptom/sign and the presence of null/severe mutations, both being predictive of more severe phenotypes. Therefore, it would be helpful to know whether siblings with the same genotype can be expected to experience comparable phenotypic expression. All non-neuronopathic sibling pairs in our referral clinic (1993–2008) with the same genotype were included. For each pair, gender, date of birth, severity score index at presentation, age at diagnosis and first symptom/sign, presence of bone involvement, spleen status, and use of enzyme replacement therapy were tabulated. There were 90 pairs of siblings: two sets of identical twins; 24 pairs of brothers, 24 pairs of sisters, and 42 pairs of mixed gender. For all measures of disease severity used, only in sibling pairs with an older sister and a younger brother were phenotypes significantly different between siblings. Thus, this large cohort of sibling pairs with type 1 Gaucher disease confirmed that, in general, the phenotypic expression in the younger sibling will be similar enough to that of an older affected sibling that genetic counseling may use those findings in a prognostic way.Keywords
This publication has 11 references indexed in Scilit:
- The female Gaucher patient: The impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)Blood Cells, Molecules, and Diseases, 2009
- Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseasesMolecular Genetics and Metabolism, 2004
- Twin pairs showing discordance of phenotype in adult Gaucher's diseaseQJM: An International Journal of Medicine, 2004
- Correlation among Genotype, Phenotype, and Biochemical Markers in Gaucher Disease: Implications for the Prediction of Disease SeverityMolecular Genetics and Metabolism, 2002
- Children with type I Gaucher disease: growing into adulthood with and without enzyme therapy.2000
- Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher diseaseQJM: An International Journal of Medicine, 1998
- 10 Gaucher's disease: genetic counselling and population screeningBailliere's Clinical Haematology, 1997
- Low-dose enzyme replacement therapy for Gaucher's disease: Effects of age, sex, genotype, and clinical features on response to treatmentThe American Journal of Medicine, 1994
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVELThe Lancet, 1989